Catalyst Wire Dossier Catalyst Wire Dossier

TOBRAMYCIN INHALATION SOLUTION PAK

TOBRAMYCIN · Genericus, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for TOBRAMYCIN INHALATION SOLUTION PAK, covering 2014-12-02 to 2023-04-10. Get the full timeline:

Most recent: FDA Approved: TOBRAMYCIN INHALATION SOLUTION PAK — Supplemental Application (Genericus, Inc.)

See pricing